Skip to main content
Open
Question
Forecasts
Track record
Unknowns
How it works
Sources
FAQ
Menu
← Evidence map
Article
Blood
2022
Ibrutinib frontline in young patients with CLL.
Barbara Eichhorst
PubMed ↗
Publisher ↗
No numbers read from the abstract.
Not cited yet
Ibrutinib frontline in young patients with CLL. | OpenQuestion